LAC Med Berhad (KLSE:LACMED)

LAC Med Berhad Income Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	201.63	183.22	150.35	106.64
Revenue Growth (YoY)	10.05%	21.86%	40.98%	-
Cost of Revenue	143.15	137.74	109.32	76.88
Gross Profit	58.48	45.48	41.03	29.77
Selling, General & Admin	27.02	17.86	16.57	10.07
Other Operating Expenses	0.41	0.35	0.25	0.19
Operating Expenses	28.09	18.53	14.71	11.81
Operating Income	30.39	26.95	26.32	17.96
Interest Expense	-0.73	-0.44	-1.01	-0.83
Interest & Investment Income	0.99	0.5	0.19	0.21
Currency Exchange Gain (Loss)	0.22	0.08	0.14	-
Other Non Operating Income (Expenses)	-0.02	-0.05	0.06	-0.16
Pretax Income	30.86	27.04	25.7	17.18
Income Tax Expense	8.99	6.65	4.95	4.11
Earnings From Continuing Operations	21.88	20.4	20.74	13.06
Minority Interest in Earnings	0.06	0	-	-
Net Income	21.94	20.4	20.74	13.06
Net Income to Common	21.94	20.4	20.74	13.06
Net Income Growth	7.55%	-1.66%	58.78%	-
Shares Outstanding (Basic)	400	2	2	2
Shares Outstanding (Diluted)	400	2	2	2
Shares Change (YoY)	19899.98%	-	-	-
EPS (Basic)	0.05	10.20	10.37	6.53
EPS (Diluted)	0.05	10.20	10.37	6.53
EPS Growth	-99.46%	-1.65%	58.81%	-
Free Cash Flow	-8.65	30.17	21.72	2.65
Free Cash Flow Per Share	-0.02	15.09	10.86	1.32
Gross Margin	29.00%	24.82%	27.29%	27.91%
Operating Margin	15.07%	14.71%	17.51%	16.84%
Profit Margin	10.88%	11.13%	13.80%	12.25%
Free Cash Flow Margin	-4.29%	16.47%	14.45%	2.48%
EBITDA	31.53	27.25	26.54	18.09
EBITDA Margin	15.64%	14.87%	17.66%	16.96%
D&A For EBITDA	1.14	0.31	0.22	0.12
EBIT	30.39	26.95	26.32	17.96
EBIT Margin	15.07%	14.71%	17.51%	16.84%
Effective Tax Rate	29.12%	24.58%	19.27%	23.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.